Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Carpal tunnel syndrome (CTS) is a common condition caused by pressure from a ligament on a nerve in the wrist, leading to pain, numbness, and weakness in the hand. Surgery to cut the ligament is often recommended when non-surgical treatments do not provide sufficient symptom relief, but it is unclear how much of the improvement is due to the surgery itself versus natural recovery or placebo effects.
The FINCATS study will compare standard carpal tunnel surgery with a placebo procedure in which the ligament is not cut. Participants and the healthcare staff caring for them after the procedure will not know which procedure was performed. The study's main question is whether cutting the ligament provides greater symptom relief than a placebo procedure. In addition, eligible patients who are not willing to participate in randomized setting are invited to join a parallel observational group. Participants in this observational group are treated within usual care pathway.
Participants in both the randomized and observational group will be followed for five years to assess symptom improvement, hand function, pain, quality of life, and any side effects. The goal is to provide reliable evidence to help patients and doctors make informed decisions about treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Carpal tunnel release | Experimental | Open carpal tunnel release: skin incision, division of the palmar aponeurosis, and transverse carpal ligament. |
|
| Placebo surgery | Placebo Comparator | Placebo surgery: Skin incision and division of palmar aponeurosis |
|
| Observational arm | Other | Open carpal tunnel release: skin incision, division of the palmar aponeurosis, and division of the transverse carpal ligament. Observational group: eligible participants included to assess potential selection bias. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Carpal tunnel release | Procedure | Open carpal tunnel release: skin incision, division of the palmar aponeurosis, and transverse carpal ligament. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient acceptable symptom state (PASS) | PASS is used as a binary global outcome using the following question: "Regarding your recovery from the carpal tunnel release, specifically pertaining to paresthesia, pain and overall function of the hand, would you be content if the clinical state of your hand would remain the same as it has been the past week?" Response options are: Yes, I would be content or No, I would not be content. | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Patient acceptable symptom state (PASS) | PASS is used as a binary global outcome measure and will be assessed using the following question: "Regarding your recovery from the carpal tunnel release, specifically pertaining to paresthesia, pain and overall function of the hand, would you be content if the clinical state of your hand would remain the same as it has been the past week?" Response options are: Yes, I would be content or No, I would not be content. |
| Measure | Description | Time Frame |
|---|---|---|
| Pillar pain - interview | Pillar pain will be assessed using two questions:
| At recruitment and 1 and 4 months after intervention. |
| Pillar pain - pressure pain thresholds |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Susanna Stjernberg-Salmela, MD, PhD | Contact | 0504274955 | +358 | Susanna.Stjernberg-Salmela@hus.fi |
| Kati MJ Jaatinen | Contact | kati.jaatinen@hus.fi |
| Name | Affiliation | Role |
|---|---|---|
| Teppo LN Järvinen, Professor | Helsinki University Central Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| HUS group, Helsinki Central University Hospital, Meilahti Bridge Hospital | Recruiting | Helsinki | Finland |
All collected IPD provided that current legislation permits it.
After publication of main results, to be specified later
To be determined
Not provided
Not provided
| ID | Term |
|---|---|
| D002349 | Carpal Tunnel Syndrome |
| ID | Term |
|---|---|
| D020423 | Median Neuropathy |
| D020422 | Mononeuropathies |
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
Not provided
Not provided
Participants are assigned to one of two groups in parallel for the duration of the study.
Not provided
Not provided
Participants, healthcare professionals other than the treating surgical team, outcome assessors, and investigators will be blinded to treatment allocation.
| Placebo surgery | Procedure | Skin incision and division of the palmar aponeurosis |
|
| 6 and 9 months and 1,2,3,4 and 5 years |
| Global Impression of Improvement (PGI-I) | A single-item patient-reported measure indicating overall perceived improvement since the start of treatment, rated on a 7-point scale from 1 (very much improved) to 7 (very much worse). | 4, 6 and 9 months and 1,2,3,4 and 5 years |
| 6-Item carpal tunnel syndrome (CTS) symptoms scale | The CTS-6 is a validated six-item patient-reported questionnaire used to assess the severity of carpal tunnel syndrome symptoms, including pain, numbness or tingling, and functional impairment, with scores ranging from 0 (least severe) and 26 (most severe). A score >12 correlates with an 80% probability of CTS. | At recruitment, 4, 6 and 9 months and 1,2,3,4 and 5 years |
| Patient-Specific Functional Scale (PSFS) | The Patient-Specific Functional Scale (PSFS) is a patient-reported measure that assesses level of functional limitations in 3-5 activities identified as important by the patient and deemed difficult to perform by the patient, due to the hand condition. The PSFS is rated on an ordinal scale from 0 (unable to perform the activity) to 10 (able to perform the activity at the same level as before the disease.) | At recruitment, 4, 6 and 9 months and 1,2,3,4 and 5 years |
| Numeric Pain Rating Scale (NRS) | A patient-reported measure for pain intensity on an 11-point scale from 0 (no pain) to 10 (worst imaginable pain). | At recruitment, 4, 6 and 9 months and 1,2,3,4 and 5 years |
| Health-related quality of life (EuroQol 5-Dimension 5-Level (EQ-5D-5L) index value) | EQ-5D-5L questionnaire, Finnish language version, using the Danish value set. Score ranges from values below 0 (health states considered worse than death) to 1.00 (full health), where higher scores indicate better health-related quality of life. | At recruitment, 4, 6 and 9 months and 1,2,3,4 and 5 years |
| Health-related quality of life: EuroQol 5-Dimensions (EQ-5D) Visual Analogue Scale (VAS) (EQ VAS) ) | EQ-5D is a generic patient rated outcome measure (PROM) comprising five health dimensions (mobility, self-care, daily activities, pain/discomfort, anxiety/depression) and a VAS. EQVAS is a vertical visual analogue scale, on which patients rate their general health on a scale from 0 (worst imaginable health state) to 100 (best imaginable health state). | At recruitment, 4, 6 and 9 months and 1,2,3,4 and 5 years |
| Harms | Harms and healthcare contacts related to the operated hand will be collected systematically and unprompted using a standardized electronic case report files (eCRF). Events will be classified by type (Adverse event, Serious Adverse Event, Suspected Unexpected Serious Adverse Reaction), attribution, timing, and nature. | Intervention (intra-operative), at 4, 6 and 9 months and 1,2,3,4 and 5 years. In addition, unprompted contacts from participant |
Pillar pain will be assessed through pressure pain thresholds on thenar and hypothenar eminences with a digital algometer |
| At recruitment and 1 and 4 months after intervention. |
| Pillar pain - palmar skin sensation | Palmar skin sensation will be assessed at thenar and hypothenar eminences with a standard evaluation tool neuropen. | At recruitment and 1 and 4 months after intervention. |
| Blinding fidelity | Blinding fidelity will be assessed by asking participants which treatment group they believe they were allocated to. Response options will include "Carpal tunnel release," "Placebo intervention," or "Unsure." | At 4 months after intervention. |
| Conduction velocity | Nerve conduction velocities will be assessed in randomized participants using standard electroneurography techniques. Measurements will quantify median nerve function across the carpal tunnel to evaluate changes after intervention. | At 4 months after intervention. |
| Medication | Need for medication due to pain. Response options: Every day, On most days of the week, 1-2 times a week, Rarely 5. Never | At recruitment, 4, 6 and 9 months and 1,2,3,4 and 5 years |
| Clinical examination | Standard hand surgical clinical examination and provocation tests: Tinell, Tethro, Phalen and atrophy evaluation | At recruitment; at 4, and 12 months; and at 5 years after primary surgery. |
| Wellbeing Services County of Pirkamaa, Tampere Central University Hospital | Not yet recruiting | Tampere | Finland |
|
| D009422 | Nervous System Diseases |
| D009408 | Nerve Compression Syndromes |
| D012090 | Cumulative Trauma Disorders |
| D013180 | Sprains and Strains |
| D014947 | Wounds and Injuries |